Hypothyroidism Disease

BASICS

DESCRIPTION
A clinical state resulting from decreased circulating levels of free thyroid hormone or from resistance to hormone action. Myxedema connotes severe hypothyroidism.
  • System(s) affected: Endocrine/Metabolic
  • Genetics:
    • No known genetic pattern for idiopathic primary hypothyroidism
    • Hypothyroidism may be associated with Type II autoimmune polyglandular syndrome, which is associated with HLA-DR3, DR4
    • Secondary hypothyroidism frequently results from treatment for Graves disease, which may be familial
  • Incidence/Prevalence in USA:
    • 5–10/1000 in general population
    • Over age 65, increases to 6–10% of women, 2–3% of men
  • Predominant age: Over 40
  • Predominant sex: Female > Male, 5-10:1
SIGNS AND SYMPTOMS
  • Symptoms
    • Onset may be insidious, subtle
    • Weakness, fatigue, lethargy
    • Cold intolerance
    • Decreased memory
    • Hearing impairment
    • Constipation
    • Muscle cramps
    • Arthralgias
    • Paresthesias
    • Modest weight gain (10 pounds [4.5 kg])
    • Decreased sweating
    • Menorrhagia
    • Depression
    • Hoarseness
    • Carpal tunnel syndrome
  • Signs
    • Dry, coarse skin
    • Dull facial expression
    • Coarsening or huskiness of voice
    • Periorbital puffiness
    • Swelling of hands and feet
    • Bradycardia
    • Hypothermia
    • Reduced systolic blood pressure
    • Increased diastolic blood pressure
    • Reduced body and scalp hair
    • Delayed relaxation of deep tendon reflexes
    • Macroglossia
    • Dilutional hyponatremia
    • Anemia (usually normochromic, normocytic)
    • Enlarged heart on chest x-ray (often due to pericardial effusion)
CAUSES
  • Post-ablative follows radioactive iodine therapy or thyroid surgery. Delayed hypothyroidism may develop in patients treated with thioamide drugs (propylthiouracil, methimazole) 4 to 25 years later.
  • Primary hypothyroidism may develop as a result of autoimmune thyroiditis, or be idiopathic
  • With goiter, most commonly due to autoimmune disease, such as Hashimoto's thyroiditis; or heritable biosynthetic defects, iodine deficiency (rare in the US), or drug induced (iodides, lithium, phenylbutazone, aminosalicylic acid)
  • Suprathyroid hypothyroidism may be due to deficiency of thyrotropin-releasing hormone (TRH) from the hypothalamus or thyroid-stimulating hormone (TSH) from the pituitary
  • Transient hypothyroidism may result from silent thyroiditis (most common in postpartum period) and subacute granulomatous thyroiditis
RISK FACTORS
  • Risk increases with increasing age
  • Autoimmune diseases

DIAGNOSIS

LABORATORY
  • Total serum thyroxine (T4) - decreased
  • T3 resin uptake - increased
  • TSH (radioimmunoassay) - elevated
  • Free T4 index (= T3 resin uptake × total serum T4) - low
  • In severe hypothyroidism: anemia, elevated cholesterol, CPK, LDH, AST, hyponatremia
Drugs that may alter lab results:
  • Thyroid supplement
  • Cortisone
  • Dopamine
  • Phenytoin
  • Estrogen or androgen therapy in excess of replacement
  • Amiodarone
  • Salicylates
Disorders that may alter lab results:
  • Any severe illness
  • Pregnancy
  • Chronic protein malnutrition
  • Hepatic failure
  • Nephrotic syndrome
PATHOLOGICAL FINDINGS
Thyroid may be small, atrophic or enlarged
SPECIAL TESTS
Radioimmunoassay
IMAGING
None necessary
DIAGNOSTIC PROCEDURES
Elevated TSH (greater than 20 µU/mL [3-20 mIU/L]) is diagnostic of primary thyroid failure

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient except for complicating emergencies (coma, hypothermia)

GENERAL MEASURES

Goals of treatment are to restore and maintain a euthyroid state

SURGICAL MEASURES

N/A

ACTIVITY

As tolerated

DIET
  • High-bulk diet may be helpful to avoid constipation
  • Low fat diet for obese patients
PATIENT EDUCATION
  • Importance of compliance with thyroid replacement therapy
  • Need for lifelong treatment
  • Report to physician any signs of infection, heart problems
  • Signs of thyrotoxicity

FOLLOW UP

PREVENTION/AVOIDANCE

N/A

POSSIBLE COMPLICATIONS
  • Treatment induced congestive heart failure in people with coronary artery disease
  • Myxedema coma - life threatening complication of hypothyroidism
  • Increased susceptibility to infection
  • Megacolon
  • Organic psychosis with paranoia
  • Adrenal crisis with vigorous treatment of hypothyroidism
  • Infertility
  • Hypersensitivity to opiates
  • Overtreatment over long periods can lead to bone demineralization
EXPECTED COURSE AND PROGNOSIS
  • With early treatment, striking transformations in appearance and mental function. Return to normal state is the rule.
  • Relapses will occur if treatment is interrupted
  • If untreated, may progress to myxedema coma

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Hyponatremia
  • Anemia
  • Idiopathic adrenocorticoid deficiency
  • Diabetes mellitus
  • Hypoparathyroidism
  • Myasthenia gravis
  • Vitiligo
  • Hypercholesterolemia
  • Mitral valve prolapse
  • Depression
  • Rapid cycling bipolar disorder
AGE-RELATED FACTORS

Pediatric: N/A
Geriatric:

  • Characteristic signs and symptoms frequently changed or absent. Hypothyroidism is common in elderly. Diagnosis based on laboratory criteria.
  • Replacement therapy is usually about two thirds of the dose used in young adults.

Others: N/A

PREGNANCY
  • Replacement therapy may need adjustment. TSH levels should be monitored monthly during first trimester.
  • Postpartum - check TSH levels at about 6 weeks
  • Painless subacute thyroiditis may occur in the postpartum period, leading to transient hypothyroidism lasting about 3 months. Treatment with replacement therapy may be warranted. Up to 30% of these individuals develop permanent hypothyroidism.
OTHER NOTES
  • Surgical procedures
    • Hypothyroid patients (mild to moderate) tolerate surgery with mortality and complications similar to euthyroid patients
    • If surgery is elective, render patient euthyroid prior to procedure
    • If surgery is urgent, proceed with the procedure with individualized replacement therapy preoperatively and postoperatively
ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.